索引超出了数组界限。
1 顾越雷, 李峰, 樊强, 等. 胃食管反流病的基础研究进展及临床诊治现状[J]. 中国普外基础与临床杂志, 2016, 23(11): 1413-1417.
2 Maev IV, Barkalova EV, Ovsepyan MA, et al. Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease[J]. Ter Arkh, 2017, 89(2): 76-83.
3 Gold BD, Pilmer B, Kierkus' J, et al. Dexlansoprazole for heartburn relief in adolescents with symptomatic, nonerosive gastro-esophageal reflux disease[J]. Dig Dis Sci, 2017, 62(11): 3059-3068.
4 崔二丽, 王智昊, 王丽波, 等. 功能性消化不良的诊治进展[J]. 中国老年学杂志, 2015, 35(9): 2564-2568.
5 Lishchuk NB, Simanenkov VI, Tikhonov SV. Differentiation therapy for non-acidic gastroesophageal reflux disease[J]. Ter Arkh, 2017, 89(4): 57-63.
6 钟良, 徐蔚佳. 胃食管反流病的诊治进展[J]. 国际消化病杂志, 2014, 34(3): 155-156, 160.
7 Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease[J]. Am J Gastroenterol, 2001, 96(1): 52-57.
8 中华医学会消化内镜学会分会. 反流性食管炎诊断及治疗指南(2003年)[J]. 中华消化内镜杂志, 2004, 21(4): 221-222.
9 Kaplan M, Tanoglu A, Sakin YS, et al. Landmark reading alterations in patients with gastro-oesophageal reflux symptoms undergoing diagnostic gastroscopy[J]. Arab J Gastroenterol, 2016, 17(4): 176-180.
10 屈坤鹏, 成晓舟. 我国部分地区胃食管反流病患病率的Meta分析[J]. 中华胃食管反流病电子杂志, 2015, 2(1): 34-44.
11 Torresan F, Mandolesi D, Ioannou A, et al. A new mechanism of gastroesophageal reflux in hiatal hernia documented by high-resolution impedance manometry: a case report[J]. Ann Gastroenterol, 2016, 29(4): 548-550.
12 张玲, 邹多武. 胃食管反流病的流行病学及危险因素[J]. 临床荟萃, 2017, 32(1): 1-4.
13 Lee SH, Jang BI, Jeon SW, et al. A multicenter, randomized, comparative study to determine the appropriate dose of lansoprazole for use in the diagnostic test for gastroesophageal reflux disease[J]. Gut Liver, 2011, 5(3): 302-307.
14 Peng S, Xiao YL, Cui Y, et al. High- dose esomeprazole is required for intraesophageal acid control in gastroesophageal reflux disease patients with hiatus hernia[J]. J Gastroenterol Hepatol, 2012, 27(5): 893-898.
15 吴晓玲, 周敏华, 谢奕丹, 等. 兰索拉唑临床应用的安全性评价与风险管理[J]. 中国药房, 2014, 25(48): 4531-4534.
16 Chun BJ, Lee DS. The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease[J]. Eur Arch Otorhinolaryngol, 2013, 270(4): 1385-1390.
17 吴玉叶. 兰索拉唑联合依托比利治疗反流性食管炎的临床效果观察[J]. 河南医学研究, 2017, 26(16): 2979-2980.
18 张征. 不同剂量质子泵抑制剂三联疗法治疗幽门螺杆菌阳性十二指肠溃疡的疗效评价[J]. 中华临床医师杂志(电子版), 2012, 6(22): 7426-7427.
19 Brzozowska I, Strzalka M, Drozdowicz D, et al. Mechanisms of esophageal protection, gastroprotection and ulcer healing by melatonin. implications for the therapeutic use of melatonin in gastroesophageal reflux disease(GERD)and peptic ulcer disease[J]. Curr Pharm Des, 2014, 20(30): 4807-4815.
20 Shivappa N, Hebert JR, Anderson LA, et al. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study[J]. Br J Nutr, 2017, 117(9): 1323-1331.
21 Iwakiri K, Sakurai Y, Shiino M, et al. A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan(20 mg and 40 mg)in patients with proton-pump inhibitor-resistant erosive esophagitis[J]. Therap Adv Gastroenterol, 2017, 10(6): 439-451.